NCT02294357 2023-11-01Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 CarfilzomibOncotherapeuticsPhase 2 Terminated45 enrolled
NCT00309907 2017-09-29Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell TransplantChildren's Oncology GroupPhase 2 Completed39 enrolled 12 charts